Physician Dispensing, Worksite Clinic

Do You Practice Good Sales?

Good Sales

Good Sales

Try Not. Do or do not, there is no try.Yoda

In his article entitled “Why Smart People Should Go Into Sales“, Andrew Yang argues that sales gets a bad rap and that more people should look at it as a viable career path. I agree with him. Sales is not about persuading someone to do something they wouldn’t otherwise want to do and requires a sophisticated set of interpersonal, organizational and analytical skills. There are good approaches and bad approaches to selling. Here are my Top 5 for Good Sales:

  1. Good Sales builds, maintains and sustains external relationships over an extended period of time.
  2. Good Sales creates value by helping people get what they want.
  3. Good Sales generates revenue by helping people get what they want.
  4. Good Sales builds organizational momentum by creating “wins”.
  5. Good Sales reinforces your brand by projecting the mission, vision and values of the organization.

Good Sales? It’s not easy. Nor should it only be practiced by “sales people”. Everyone sells.

Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading